Medtronic plc (NYSE:MDT) is one of the top low volatility healthcare stocks to buy now. On July 16, Mizuho raised the firm’s ...

In the latest trading session, Medtronic (MDT) closed at $91.97, marking a -1.04% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.02% for the day. At the ...

The company showcases solid financial health with steady revenue, strong free cash flow, and reliable earnings.

One key theme that runs through the two examples here is consistency. On that score, Johnson & Johnson has the best track ...

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward broader adoption.

Medtronic MDT underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a concise overview of recent ratings by ...

For the second quarter, Texas Instruments reported revenue of $4.45 billion, up 16% year-over-year and above the analyst ...

We came across a bullish thesis on Medtronic plc on Max Dividends’s Substack. In this article, we will summarize the bulls’ ...

CFRA has a “buy” rating and $99 price target for MDT stock, which closed at $89.22 on July 15. More from U.S. News Recession 2025: What to Watch and How to Prepare ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Medtronic on July 15 and set a price target of $101.00. The company’s shares closed yesterday at $89.78. Take advantage of TipRanks ...

Analysts fell to the sidelines weighing in on Medtronic (MDT – Research Report) and Exelixis (EXEL – Research Report) with neutral ratings, indicating that the experts are nei ...

Key Points Medtronic faces several challenges, including slow revenue growth and uncertainty related to tariffs.However, the company has significant strengths, including a massive opportunity for its ...